Filed: 5/8/2024ACC: 0001104659-24-058588
📋 What this filing means
RIVERVEST VENTURE MANAGEMENT LLC filed this quarterly 13F‑HR report disclosing 4 equity positions with a total reported market value of $8.14M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
4
Positions
$8.14M
Total AUM (reported)
6.96M
Total Shares
Allocation by class
COMMON$8.14M100.0%
Portfolio Concentration
Top 3$8.07M99.1%
4–10$69.8K0.9%
Top 3 weight
99.1%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 6.96M
Sole
Full voting authority
6.91M
shares
% of voting shares99.2%
Shared
Joint voting authority
52.88K
shares
% of voting shares0.8%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole3
Shared0
Other1
Dominant voting typeSole · 99.2% of voting shares
Institutional Holdings4
Rows:
Reneo Pharmaceuticals, Inc.
SOLEShares2.53M
TypeSH
Market value$4.21M
51.67%
Sole
2.53M
Shared
0.00
None
0.00
Spruce Bioscience, Inc.
SOLEShares2.94M
TypeSH
Market value$2.31M
28.35%
Sole
2.94M
Shared
0.00
None
0.00
Xilio Therapeutics, Inc.
SOLEShares1.44M
TypeSH
Market value$1.56M
19.12%
Sole
1.44M
Shared
0.00
None
0.00
Vapotherm, Inc.
OTRShares52.88K
TypeSH
Market value$69.8K
0.86%
Sole
0.00
Shared
52.88K
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Reneo Pharmaceuticals, Inc.SOLE | Common | 2.53M | SH | $4.21M 51.67% | 2.53M | 0.00 | 0.00 |
Spruce Bioscience, Inc.SOLE | Common | 2.94M | SH | $2.31M 28.35% | 2.94M | 0.00 | 0.00 |
Xilio Therapeutics, Inc.SOLE | Common | 1.44M | SH | $1.56M 19.12% | 1.44M | 0.00 | 0.00 |
Vapotherm, Inc.OTR | Common | 52.88K | SH | $69.8K 0.86% | 0.00 | 52.88K | 0.00 |